Suivre
Anna Latorre
Anna Latorre
Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology
Adresse e-mail validée de ucl.ac.uk
Titre
Citée par
Citée par
Année
Abnormal salivary total and oligomeric alpha-synuclein in Parkinson’s disease
G Vivacqua, A Latorre, A Suppa, M Nardi, S Pietracupa, R Mancinelli, ...
PloS one 11 (3), e0151156, 2016
1282016
The use of transcranial magnetic stimulation as a treatment for movement disorders: a critical review
A Latorre, L Rocchi, A Berardelli, KP Bhatia, JC Rothwell
Movement Disorders 34 (6), 769-782, 2019
732019
Poor self-awareness of levodopa-induced dyskinesias in Parkinson's disease: clinical features and mechanisms
S Pietracupa, A Fasano, G Fabbrini, M Sarchioto, M Bloise, A Latorre, ...
Parkinsonism & Related Disorders 19 (11), 1004-1008, 2013
672013
Non-invasive suppression of essential tremor via phase-locked disruption of its temporal coherence
SR Schreglmann, D Wang, RL Peach, J Li, X Zhang, A Latorre, E Rhodes, ...
Nature communications 12 (1), 363, 2021
632021
Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study
A Tessitore, P Marano, N Modugno, FE Pontieri, N Tambasco, M Canesi, ...
Journal of neurology 265, 1124-1137, 2018
622018
Fatigue in Parkinson's disease: motor or non-motor symptom?
G Fabbrini, A Latorre, A Suppa, M Bloise, M Frontoni, A Berardelli
Parkinsonism & related disorders 19 (2), 148-152, 2013
582013
Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up
M Sensi, G Cossu, F Mancini, M Pilleri, M Zibetti, N Modugno, R Quatrale, ...
Parkinsonism & related disorders 38, 90-92, 2017
552017
Unravelling the enigma of cortical tremor and other forms of cortical myoclonus
A Latorre, L Rocchi, F Magrinelli, E Mulroy, A Berardelli, JC Rothwell, ...
Brain 143 (9), 2653-2663, 2020
512020
The interindividual variability of transcranial magnetic stimulation effects: implications for diagnostic use in movement disorders
A Latorre, L Rocchi, A Berardelli, KP Bhatia, JC Rothwell
Movement Disorders 34 (7), 936-949, 2019
512019
Adherence to anti-Parkinson drug therapy in the "REASON" sample of Italian patients with Parkinson's disease: the linguistic validation of the Italian version of the "Morisky …
CR Fabbrini G, Abbruzzese G, Barone P, Antonini A, Tinazzi M, Castegnaro G ...
Neurological Science 34 (11), 2015-22, 2013
492013
Ten‐year reflections on the neurophysiological abnormalities of focal dystonias in humans
A Conte, L Rocchi, A Latorre, D Belvisi, JC Rothwell, A Berardelli
Movement Disorders 34 (11), 1616-1628, 2019
422019
Pathophysiology of pain and fatigue in Parkinson's disease
A Berardelli, A Conte, G Fabbrini, M Bologna, A Latorre, L Rocchi, ...
Parkinsonism & related disorders 18, S226-S228, 2012
412012
Twenty years on: Myoclonus‐dystonia and ε‐sarcoglycan—neurodevelopment, channel, and signaling dysfunction
E Menozzi, B Balint, A Latorre, EM Valente, JC Rothwell, KP Bhatia
Movement Disorders 34 (11), 1588-1601, 2019
402019
Impaired automatic but intact volitional inhibition in primary tic disorders
V Rawji, S Modi, A Latorre, L Rocchi, L Hockey, K Bhatia, E Joyce, ...
Brain 143 (3), 906-919, 2020
392020
Dissecting the Phenotype and Genotype of PLA2G6‐Related Parkinsonism
F Magrinelli, S Mehta, G Di Lazzaro, A Latorre, MJ Edwards, B Balint, ...
Movement Disorders 37 (1), 148-161, 2022
372022
On the use of TMS to investigate the pathophysiology of neurodegenerative diseases
V Rawji, A Latorre, N Sharma, JC Rothwell, L Rocchi
Frontiers in neurology 11, 584664, 2020
362020
Motor cortical excitability during voluntary inhibition of involuntary tic movements
C Ganos, L Rocchi, A Latorre, L Hockey, C Palmer, EM Joyce, KP Bhatia, ...
Movement disorders 33 (11), 1804-1809, 2018
342018
Primary motor cortex long‐term plasticity in multiple system atrophy
A Suppa, L Marsili, F Di Stasio, A Latorre, AK Parvez, C Colosimo, ...
Movement Disorders 29 (1), 97-104, 2014
312014
Expanding the Spectrum of Movement Disorders Associated With C9orf72 Hexanucleotide Expansions
C Estevez-Fraga, F Magrinelli, D Hensman Moss, E Mulroy, G Di Lazzaro, ...
Neurology: Genetics 7 (2), e575, 2021
272021
KCNN2 mutation in autosomal‐dominant tremulous myoclonus‐dystonia
B Balint, R Guerreiro, S Carmona, N Dehghani, A Latorre, C Cordivari, ...
European journal of neurology 27 (8), 1471-1477, 2020
272020
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20